reference/12748148

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12748148

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	215
issn	1862-1783 1673-1581
issueIdentifier	3
pageRange	207-215
publicationName	Journal of Zhejiang University. Science. B
startingPage	207
bibliographicCitation	Hong W, Wang K, Zhang Y, Kou J, Hong D, Su D, Mao W, Yu X, Xie F, Wang X. Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population. Journal of Zhejiang University-SCIENCE B. 2013 Mar 10;14(3):207–15. doi: 10.1631/jzus.b1200101.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_614f655d15b86b47d27fab878ff28835 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2eb6508818a8b27150a0c8f68b936846 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29fe2e9230809f1545b9d42bd2cdeac0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4646498f757290d67df69d3d2e2589f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66f701819ec4093daf7b6dd506c96e55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_016be408948ca65c35b4df1e7530479d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f9b8e9a4394ba6ebc3b0d152a51d7f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe60f53dec55b44baf1063e52246bc5b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbdb7bb733094125d506c1c282d3c709 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_913a679072f4dfe4f5df5f09481bc992
date	2013-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1631/jzus.b1200101 https://pubmed.ncbi.nlm.nih.gov/PMC3596571 https://pubmed.ncbi.nlm.nih.gov/23463763
isPartOf	https://portal.issn.org/resource/ISSN/1862-1783 https://portal.issn.org/resource/ISSN/1673-1581 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32257
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population
discusses	http://id.nlm.nih.gov/mesh/M0137645 http://id.nlm.nih.gov/mesh/M0009130 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M000754277
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.5.1.20 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f711b441c08d32e3c24e3fd3df4a2c3d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_216b3f57d0f687434bc29fb5794589c0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4524

Total number of triples: 43.